Search Results - "Nunn, Anthony J"

Refine Results
  1. 1

    Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool by Bracken, Louise E, Nunn, Anthony J, Kirkham, Jamie J, Peak, Matthew, Arnott, Janine, Smyth, Rosalind L, Pirmohamed, Munir, Turner, Mark A

    Published in PloS one (03-01-2017)
    “…To develop and test a new tool to assess the avoidability of adverse drug reactions that is suitable for use in paediatrics but which is also applicable to a…”
    Get full text
    Journal Article
  2. 2

    Potentially harmful excipients in neonatal medicines: a pan-European observational study by Nellis, Georgi, Metsvaht, Tuuli, Varendi, Heili, Toompere, Karolin, Lass, Jana, Mesek, Inge, Nunn, Anthony J, Turner, Mark A, Lutsar, Irja

    Published in Archives of disease in childhood (01-07-2015)
    “…ObjectivesWe aimed to describe administration of eight potentially harmful excipients of interest (EOI)—parabens, polysorbate 80, propylene glycol, benzoates,…”
    Get full text
    Journal Article
  3. 3

    Adverse drug reactions causing admission to a paediatric hospital by Gallagher, Ruairi M, Mason, Jennifer R, Bird, Kim A, Kirkham, Jamie J, Peak, Matthew, Williamson, Paula R, Nunn, Anthony J, Turner, Mark A, Pirmohamed, Munir, Smyth, Rosalind L

    Published in PloS one (04-12-2012)
    “…To obtain reliable information about the incidence of adverse drug reactions, and identify potential areas where intervention may reduce the burden of…”
    Get full text
    Journal Article
  4. 4

    Development and inter-rater reliability of the Liverpool adverse drug reaction causality assessment tool by Gallagher, Ruairi M, Kirkham, Jamie J, Mason, Jennifer R, Bird, Kim A, Williamson, Paula R, Nunn, Anthony J, Turner, Mark A, Smyth, Rosalind L, Pirmohamed, Munir

    Published in PloS one (14-12-2011)
    “…To develop and test a new adverse drug reaction (ADR) causality assessment tool (CAT). A comparison between seven assessors of a new CAT, formulated by an…”
    Get full text
    Journal Article
  5. 5

    Enhancing communication about paediatric medicines: lessons from a qualitative study of parents' experiences of their child's suspected adverse drug reaction by Arnott, Janine, Hesselgreaves, Hannah, Nunn, Anthony J, Peak, Matthew, Pirmohamed, Munir, Smyth, Rosalind L, Turner, Mark A, Young, Bridget

    Published in PloS one (10-10-2012)
    “…There is little research on parents' experiences of suspected adverse drug reactions in their children and hence little evidence to guide clinicians when…”
    Get full text
    Journal Article
  6. 6

    Prophylactic ranitidine treatment in critically ill children – a population pharmacokinetic study by Hawwa, Ahmed F., Westwood, Paul M., Collier, Paul S., Millership, Jeffrey S., Yakkundi, Shirish, Thurley, Gillian, Shields, Mike D., Nunn, Anthony J., Halliday, Henry L., McElnay, James C.

    Published in British journal of clinical pharmacology (01-05-2013)
    “…Aims To characterize the population pharmacokinetics of ranitidine in critically ill children and to determine the influence of various clinical and…”
    Get full text
    Journal Article
  7. 7

    Adverse drug reactions and off‐label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital by Bellis, Jennifer R., Kirkham, Jamie J., Nunn, Anthony J., Pirmohamed, Munir

    Published in British journal of clinical pharmacology (01-03-2014)
    “…Aims To examine the impact of off‐label and unlicensed (OLUL) prescribing on adverse drug reactions (ADRs) causing unplanned admissions to a paediatric…”
    Get full text
    Journal Article
  8. 8

    A systematic review of the use of dosage form manipulation to obtain required doses to inform use of manipulation in paediatric practice by Richey, Roberta H., Hughes, Clare, Craig, Jean V., Shah, Utpal U., Ford, James L., Barker, Catrin E., Peak, Matthew, Nunn, Anthony J., Turner, Mark A.

    Published in International journal of pharmaceutics (25-02-2017)
    “…[Display omitted] This study sought to determine whether there is an evidence base for drug manipulation to obtain the required dose, a common feature of…”
    Get full text
    Journal Article
  9. 9

    Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children by Duncan, Jennifer C., Bracken, Louise E., Nunn, Anthony J., Peak, Matthew, Turner, Mark A.

    Published in International journal of clinical pharmacy (01-12-2022)
    “…Background Medicines designed for adults may be inappropriate for use in children in terms of strength, dosage form and/or excipient content. There is…”
    Get full text
    Journal Article
  10. 10

    High variability in the dosing of commonly used antibiotics revealed by a Europe-wide point prevalence study: implications for research and dissemination by Metsvaht, Tuuli, Nellis, Georgi, Varendi, Heili, Nunn, Anthony J, Graham, Susan, Rieutord, Andre, Storme, Thomas, McElnay, James, Mulla, Hussain, Turner, Mark A, Lutsar, Irja

    Published in BMC pediatrics (16-04-2015)
    “…Antibiotic dosing in neonates varies between countries and centres, suggesting suboptimal exposures for some neonates. We aimed to describe variations and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Manipulation of drugs to achieve the required dose is intrinsic to paediatric practice but is not supported by guidelines or evidence by Richey, Roberta H, Shah, Utpal U, Peak, Matthew, Craig, Jean V, Ford, James L, Barker, Catrin E, Nunn, Anthony J, Turner, Mark A

    Published in BMC pediatrics (21-05-2013)
    “…A lack of age-appropriate formulations can make it difficult to administer medicines to children. A manipulation of the dosage form may be required to achieve…”
    Get full text
    Journal Article
  13. 13

    Medicines prescription patterns in European neonatal units by Mesek, Inge, Nellis, Georgi, Lass, Jana, Metsvaht, Tuuli, Varendi, Heili, Visk, Helle, Turner, Mark A., Nunn, Anthony J., Duncan, Jennifer, Lutsar, Irja

    Published in International journal of clinical pharmacy (01-12-2019)
    “…Background Hospitalized neonates receive the highest number of drugs compared to all other age groups, but consumption rates vary between studies depending on…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Product Substitution as a Way Forward in Avoiding Potentially Harmful Excipients in Neonates by Nellis, Georgi, Metsvaht, Tuuli, Varendi, Heili, Lass, Jana, Duncan, Jennifer, Nunn, Anthony J., Turner, Mark A., Lutsar, Irja

    Published in Paediatric drugs (01-06-2016)
    “…Objectives Our objectives were to explore the possibility of avoiding neonatal exposure to potentially harmful excipients of interest (EOI)—parabens,…”
    Get full text
    Journal Article
  16. 16

    What can we learn from parents about enhancing participation in pharmacovigilance? by Arnott, Janine, Hesselgreaves, Hannah, Nunn, Anthony J., Peak, Matthew, Pirmohamed, Munir, Smyth, Rosalind L., Turner, Mark A., Young, Bridget

    Published in British journal of clinical pharmacology (01-04-2013)
    “…Aims To investigate parents' views and experiences of direct reporting of a suspected ADR in their child. Methods We audio‐recorded semi‐structured qualitative…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Unlicensed and off label drug use in paediatric wards: prospective study by Turner, Sean, Longworth, Alexandra, Nunn, Anthony J, Choonara, Imti

    Published in BMJ (31-01-1998)
    “…Abstract Objective: To determine the extent of use in children in hospital of drugs that are not specifically licensed for use in children (unlicensed) and of…”
    Get full text
    Journal Article
  19. 19

    Clinical coding of prospectively identified paediatric adverse drug reactions--a retrospective review of patient records by Bellis, Jennifer R, Kirkham, Jamie J, Nunn, Anthony J, Pirmohamed, Munir

    Published in BMC pharmacology & toxicology (17-12-2014)
    “…National Health Service (NHS) hospitals in the UK use a system of coding for patient episodes. The coding system used is the International Classification of…”
    Get full text
    Journal Article
  20. 20

    A Comprehensive List of Items to be Included on a Pediatric Drug Monograph by Kelly, Lauren E, Ito, Shinya, Woods, David, Nunn, Anthony J, Taketomo, Carol, de Hoog, Matthijs, Offringa, Martin

    “…Children require special considerations for drug prescribing. Drug information summarized in a formulary containing drug monographs is essential for safe and…”
    Get full text
    Journal Article